Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

Browse by Journal or other publication

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Publication Date | Item type | No Grouping
Jump to: Article
Number of items: 3.

Article

Héricé, Charlotte and Patel, Amisha A. and Sakata, Shuzo (2019) Circuit mechanisms and computational models of REM sleep. Neuroscience Research, 140. pp. 77-92. ISSN 0168-0102

Patkar, Shalmali Satish and Farr, T.D. and Cooper, E and Dowell, F.J. and Carswell, Hilary (2011) Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery. Neuroscience Research, 71 (1). pp. 78-84.

Ozeki, Yuji and Pickard, Benjamin S and Kano, Shin-ichi and Malloy, Mary P and Zeledon, Mariela and Sun, Daniel Q and Fujii, Kumiko and Wakui, Keiko and Shirayama, Yukihiko and Fukushima, Yoshimitsu and Kunugi, Hiroshi and Hashimoto, Kenji and Muir, Walter J and Blackwood, Douglas H and Sawa, Akira (2011) A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression. Neuroscience Research, 69 (2). pp. 154-60.

This list was generated on Thu Jul 18 16:57:11 2019 BST.